Ascletis Pharma (OTCMKTS:ASCLF) Trading Up 4.8% – Still a Buy?

Ascletis Pharma Inc. (OTCMKTS:ASCLF) shares rose 4.8% during mid-day trading on Tuesday . The stock traded as high as $2.20 and last traded at $2.20. Approximately 200 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 3,273 shares. The stock had previously closed at $2.10.

Ascletis Pharma Trading Down 8.0%

The company’s 50-day simple moving average is $2.01 and its 200 day simple moving average is $1.73.

Ascletis Pharma Company Profile

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).